Combination of
Flupentixol Typical antipsychotic
Melitracen Tricyclic antidepressant
Clinical data
Routes of
ATC code N06CA02 (WHO)
Legal status
Legal status
  • ℞ (Prescription only)

Flupentixol/melitracen (trade name Deanxit, Placida, Franxit, Anxidreg) is a combination of two psychoactive agents which has antidepressant properties. It is designed for short term usage only. It is produced by Lundbeck.[1]

Flupentixol/melitracen were banned in India by the country's Ministry of Health and Family Welfare on July 11, 2014,[2] and Lundbeck plans to take legal action to have the ban lifted.[3]

Other Brand names

Brand names include:

See also


  1. Sweetman, Sean C., ed. (2009). "Preparations". Martindale: The complete drug reference (36th ed.). London: Pharmaceutical Press. p. 2607. ISBN 978-0-85369-840-1.
  2. "Ministry of Health and Family Welfare (Department of Health and Family Welfare) Notification, New Delhi" (PDF). The Gazette of India. July 11, 2014. Retrieved March 19, 2015 via drugscontrol.org.
  3. Soma Das, ET Bureau (July 25, 2014). "Lundbeck to seek legal recourse after health ministry bans Deanxit again". Economic Times. Retrieved March 19, 2015.

This article is issued from Wikipedia - version of the 11/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.